This paper describes a method for the determination of indoleamine (5-hydroxytryptamine) and its precursor (5-hydroxytryptophan) and metabolites (5-hydroxyindoleacetic acid and 5-hydroxytryptophol) simultaneously with catecholamines (norepinephrine, epinephrine and dopamine) and their precursor (L-3,4-dihydroxyphenylalanine) and metabolites (normetanephrine, metanephrine, 3-methoxytyramine, 3,4-dihydroxymandelic acid, 3,4-dihydroxyphenylacetic acid, vanillylmandelic acid, homovanillic acid, 3,4-dihydroxyphenylethylene glycol and 4-hydroxy-3-methoxyphenylethylene glycol). The method uses reversed-phase liquid chromatography with postcolumn fluorescence derivatization involving a periodate oxidation. This is followed by reaction with meso-l,2-diphenylethylenediamine in the presence of hexacyanoferrate(III).
Indoleamine (5-hydroxytryptamine) and catecholamines (for abbreviations, see Table 1 ) play important roles as neurotransmitters in the control and regulation of many brain functions. In order to evaluate the functions, not only the concentration levels of the transmitters, but also those of the precursors and metabolites (for abbreviations, see Table 1 ) should be measured. A number of methods have been used to determine tissue levels of these compounds.1'2 Among the methods, liquid chromatographic (LC) methods with electrochemical detection (ECD)3-13 have been extensively used to determine the compounds in brain tissue. Due to the inherent problem of the short lifetime of electrochemical cells in the detector, a number of investigators have used LC with fluorometric detection for the quantification of 5-HT14,15 and catecholamines. 16 We have reported a reversed-phase LC method for the determination of catechol and 4-hydroxy-3-methoxyphenyl compounds by postcolumn derivatization involving a periodate oxidation into the corresponding oquinones, followed by fluorescence reaction with meso-1,2-diphenylethylenediamine (DPE). 17 The LC have been successfully employed for the determination of free catecholamines and their precursor, and their metabolites in urine and plasma. 18 We found that 5-HT and their related compounds (Table 1) could also react with 
Experimental
Reagents and solutions Indoleamine-related compounds were purchased from Nacalai Tesque (Kyoto, Japan). Isoproterenol (IP) and standard samples of catecholamine-related compounds were obtained as described previously17, and DPE was synthesized as described previously.19 Probenecid and pargyline were obtained from Sigma (St. Louis, USA). All other chemicals were of reagent grade. The standard solutions of 5-HT, catecholamines and their related compounds were prepared in 10 mM hydrochloric acid and stored at -70° C. Probenecid was dissolved in 0.1 M sodium hydroxide and the solution was neutralized to pH 7.0 with 0.1 M hydrochloric acid (50 mg/ ml). Pargyline hydrochloride (18.7 mg/ ml) was dissolved in 0.9% saline.
High performance LC system and operating conditions
The LC system was essentially the same as that mentioned previously. 17 The separation was performed on a TSKgel ODS-80TM column (particle size, 5 µm; 250X4.6 mm i.d.; TOSOH, Tokyo, Japan) with isocratic elution using 30 mM citrate buffer (pH 2.5) containing 0.4 mM sodium octanesulfonate (SOS) and 5.5% (v/v) acetonitrile as a mobile phase, which was pumped at a flow-rate of 0.8 ml/ min. An aqueous solution of 10 mM sodium periodate and 3 mM potassium hexacyanoferrate(III), and an aqueous 70% (v/ v) ethanol solution of 30 mM DPE and 0.14 M sodium methylate were introduced to the column eluate at the flow-rates of 0.3 ml/ min, for the postcolumn derivatization.
Animal procedures
Male Sprague-Dawley rats (200 -275 g) were injected intraperitoneally with probenecid (200 mg/ kg), pargyline (75 mg/ kg), or 0.9% saline (4 ml/ kg, as a control). All animals were sacrificed by decapitation 1 h after the treatment, then the brains were quickly removed and dissected into cerebral cortex, striatum, hypothalamus and hippocampus.20 Each tissue was immediately chilled on ice and stored at -70° C until assayed (up to 2 months).
Analytical procedures Probenecid and saline. To the piece of tissue (50 mg) was added 10 µl of IP (internal standard; 2.5 nmol/ml for cerebral cortex, hypothalamus and hippocampus, and 5 nmol/ ml for striatum). The mixture was homogenized in 450 µl of 30 mM citrate buffer (pH 2.5) containing 0.4 mM SOS and centrifuged at 20000g at 4° C for 15 min. The supernatant was passed through a cellulose acetate membrane filter (Maishori Disc W-3-5, TOSOH), and then a 100-µ1 portion of the filtrate was subjected to LC. Pargyline. To the above mentioned supernatant (4O0µ1) was added 400 µl of cyclohexane. The mixture was vortexed and centrifuged at 3500g at 4°C for 10 min. The aqueous layer was passed through a cellulose membrane filter, and a 100-µ1 portion of the filtrate was used for LC. Results and Discussion LC conditions Figure 1 shows a chromatogram obtained with a standard mixture of four indoleamine-related compounds, thirteen catecholamine-related compounds and IP (18 species in total). These compounds could be isocratically separated within 120 min under the LC conditions. The fluorescence excitation and emission maxima of indoleamine-related compounds were around 320 and 460 nm, respectively although catecholaminerelated compounds had the maxima around 350 and 480 nm, respectively; 350 and 480 nm were used. Their retention times and relative peak heights are shown in The optimal ranges varied from 1 to 15 mM depending on the compounds. On the other hand, indoleaminerelated compounds and the catechol compounds with amino moiety (E, NE, DA, L-DOPA and IP) did not require the periodate. Potassium hexacyanoferrate(III) caused indoleamine-related compounds to give the maximum peak heights at 20 -30 mM, but 1-8 mM for catecholamine-related compounds. The optimum pH values were 7.0 -8.5 for indoleamine-related compounds but 5.0 -6.6 for catecholamine-related compounds; pH 6.5 was selected. When the indoleamine-and catecholamine-related compounds were measured simultaneously in the brain under the above mentioned derivatization conditions, L-DOPA, DOPAC and HVA were not detectable owing to their low concentrations. Therefore, compromise concentrations of sodium periodate (10 mM) and potassium hexacyanoferrate(III) (3 mM) were recommended for the sensitive detection of L-DOPA, DOPAC and HVA. Table 2 Retention times, relative peak heights and detection limites (DL; S/N=3) for indoleamine-and catecholamine-related compounds and IP, and relative standard deviations (RSD) of the present method a. The peak height for 5-HT was taken as 100. b. Portions (100 µl) of the same standard mixture as in Fig. 1 were subjected to LC; n=10. Table 2 . Calibration curves, detection limits and precision of the method The calibration curves were linear in the range (pmol/ ml) of 1-400 for indoleamine-related compounds and L-DOPA; 10 -3000 for DOMA, DOPEG, VMA and MOPEG; and 0.3 -300 for the other catecholaminerelated compounds and IP. The detection limits for indoleamine, catecholamines and their related compounds and IP were varied from 13 to 570 fmol on column depending on the compounds ( Table 2 ). The precision of the method with respect to repeatability was established ( Table 2 ). The RSDs did not exceed 3.1%.
Sample preparation
Indoleamine, catecholamines and their related compounds in rat brain tissue were most effectively extracted by homogenization in 30 mM citrate buffer (pH 2.5) containing SOS. The recoveries of the standard compounds added to whole brain homogenate (50 mg wet weight/ 450 µl) in amounts of 10 nmol for VMA and MOPEG and 0.1 nmol for the others and IP were 95 -100%, and each RSD (n=5) did not exceed 3.1%. In comparison, extractions by homogenization in perchloric acids and sonication in perchloric acid21 could not be applied to the present method; in particular, 60 -70% of 5-HT, L-DOPA, 3MT and HVA were rapidly destroyed in the extraction procedures.
Administered pargyline was transferred to the brain and existed in LC samples; it gave a fluorescent peak (retention time 115 min; excitation and emission maxima, 320 and 460 nm, respectively), and interfered with the determination of 5-HT. The removal of pargyline from the LC samples was attained by extraction with cyclohexane, hexane and chloroform, but 5-HT and 5-HIAA were also extracted with hexane and chloroform; cyclohexane was selected.
Determination of indoleamine, catecholamines and their precursors and metabolites Figure 2 shows typical chromatograms (A, B and C) obtained with rat striatal samples after the rats received intraperitoneal injections of saline, probenecid and pargyline, respectively. Similar chromatograms were observed in the other brain regions. The peaks could be identified as follows: (a) their retention times and fluorescence excitation and emission spectra coincided with those of the standard compounds; (b) an increase in peak heights was observed when they were cochromatographed with the standards; and (c) fluorescence response to the change in periodate concentration (1-20 mM) in the reagent solution was the same as that for the standard compounds. No peaks were detected when DPE was omitted from the reagent solution.
The simplicity in the chromatograms can illustrate the Table 4 Regional distribution (nmol/g wet tissue) of indoleamine-and catecholamine-related compounds in rat brain tissues, and effects of pargyline and probenecid a.
b.
Mean±standard deviation Not detected at S/N=5.
, and the number in parentheses refers to the number of animals in each group.
efficiency and specificity of the LC system. This method is comparable in terms of sensitivity, simplicity and reproducibility to the LC-ECD methods reported so far,3-9, 22-24 and it has a higher selectivity, attributable to the highly selective fluorescence reaction. This is the first fluorescence derivatization LC to measure concurrently 5-HT, catecholamines and their related compounds.
The results of the determination of several areas (striatum, cerebral cortex, hypothalamus, and hippocampus) of rat brains are shown in Table 4 ; 5-HT, 5-HIAA, NE, DA, 3MT, L-DOPA, DOPAC and HVA could be measured in all the areas.
The values in Table 4 agreed in general with the available data published.5,6,24-26 Our notable disagreement with the previously reported data6,13 involves the L-DOPA level; this method gave higher values than previously reported methods.
The reason remains unknown. The concentration levels of these compounds in the cerebral cortex, hypothalamus, hippocampus and striatum were measured after the administration of pargyline and probenecid to rats, of which action mechanisms are fairly well understood. The results (Table 4) were consistent with their known effect. 
